NCT05294211 - Safety and Performance of a Fetal Monitoring System | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

August 31, 2022

Primary Completion Date

January 24, 2023

Study Completion Date

January 24, 2023

Conditions

Pregnancy

Interventions

DEVICE

M•care™ System

The M•care™ System will be applied for monitoring of fetal heart rate (FHR), maternal heart rate (MHR) and uterine activity (UA)

DEVICE

Cardiotocography (CTG)

A standard of care CTG device will be applied for monitoring of fetal heart rate (FHR), maternal heart rate (MHR) and uterine activity (UA)

Trial Locations (1)

NorthShore University Health System, Evanston